首页> 外文期刊>The Journal of Immunology: Official Journal of the American Association of Immunologists >Protein kinase C{alpha}-mediated chemotaxis of neutrophils requires NF-{kappa}B activity but is independent of TNF{alpha} signaling in mouse skin in vivo.
【24h】

Protein kinase C{alpha}-mediated chemotaxis of neutrophils requires NF-{kappa}B activity but is independent of TNF{alpha} signaling in mouse skin in vivo.

机译:蛋白激酶C {α}介导的嗜中性粒细胞趋化性需要NF-κB活性,但在小鼠体内与皮肤中的TNF {α}信号无关。

获取原文
获取原文并翻译 | 示例
           

摘要

Protein kinase C (PKC) isoforms are major regulators of cutaneous homeostasis and mediate inflammation in response to 12-O-tetradecanoylphorbol-13-acetate (TPA). We have previously reported that transgenic mice overexpressing PKCalpha in the skin exhibit severe intraepidermal neutrophilic inflammation and keratinocyte apoptosis when treated topically with TPA. Activation of PKCalpha increases the production of TNFalpha and the transcription of chemotactic factors (MIP-2, KC, S100A8/A9), vascular endothelial growth factor, and GM-CSF in K5-PKCalpha keratinocytes. In response to PKCalpha activation, NF-kappaB translocates to the nucleus and this is associated with IkappaB phosphorylation and degradation. Preventing IkappaB degradation reduces both the expression of inflammation-associated genes and chemoattractant release. To determine whether TNFalpha mediated NF-kappaB translocation and subsequent expression of proinflammatory factors, K5-PKCalpha mice were treated systemically with a dimeric soluble form of p75 TNFR (etanercept) or crossed with mice deficient for both TNFR isoforms, and keratinocytes were cultured in the presence of TNFalpha-neutralizing Abs. The in vivo treatment and TNFR deficiency did not prevent inflammation, and the in vitro treatment did not prevent NF-kappaB nuclear translocation after TPA. Together these results implicate PKCalpha as a regulator of a subset of cutaneous cytokines and chemokines responsible for intraepidermal inflammation independent of TNFalpha. PKCalpha inhibition may have therapeutic benefit in some human inflammatory skin disorders.
机译:蛋白激酶C(PKC)亚型是皮肤稳态的主要调节剂,可响应12-O-十四烷酰佛波醇13-乙酸盐(TPA)介导炎症。我们以前曾报道过,用TPA局部治疗时,皮肤中过表达PKCalpha的转基因小鼠表现出严重的表皮中性粒细胞炎症和角质形成细胞凋亡。 PKCalpha的激活增加了K5-PKCalpha角质形成细胞中TNFalpha的产生和趋化因子(MIP-2,KC,S100A8 / A9),血管内皮生长因子和GM-CSF的转录。响应PKCalpha激活,NF-κB易位至细胞核,这与IkappB的磷酸化和降解有关。防止IkappaB降解可减少炎症相关基因的表达和化学吸引剂的释放。为了确定TNFalpha介导的NF-κB易位和促炎因子的后续表达,将K5-PKCalpha小鼠全身性地用p75 TNFR(依那西普)二聚体可溶形式处理或与既缺乏TNFR亚型的小鼠杂交,又在其中培养了角质形成细胞。 TNFalpha中和抗体的存在。体内治疗和TNFR缺乏不能预防炎症,而体外治疗也不能预防TPA后NF-κB核移位。这些结果共同暗示了PKCalpha是负责表皮内炎症的皮肤细胞因子和趋化因子的一个调节子,而与TNFalpha无关。 PKCalpha抑制在某些人类炎症性皮肤病中可能具有治疗作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号